Hemp Naturals Premium CBD Gummies Are Now Available Smokers World

MIAMI, FL / ACCESSWIRE / August 28, 2020 / Hemp Naturals Inc. (OTC PINK:HPMM) has proudly announced that it has recently launched an all-new line of Premium CBD products and Hand Sanitizers in the market. These new products will now be available at Smokers World, located at 18517 West Dixie Highway, Miami Florida 33180 this week onwards and they’re a great addition to the growing availability of our CBD Gummies.

CBD is basically a superfood that when taken regularly, provides a broad host of amazing physiological benefits. Also, each product is handcrafted and proudly made in the USA. “Our hand-crafted CBD Gummies are FDA audited and are produced in a GMP compliant facility with pure Colorado hemp CBD.” The spokesperson added. Each product manufactured by the company is not only all-natural but also organic, gluten free and non-GMO. Furthermore, precisely 25mg of hemp extract is used per gummy and these products are also third-party tested and are certified for being free of any kind of THC, chemicals and pesticides.

This is a very exciting time for CBD companies to begin exploring new ways to improve the lives of those in our communities at Hemp Naturals. We are experiencing the start of a new age in this country, when people’s access to an improved quality of life is going to change dramatically through everyday products, and we are blessed and thrilled to help carry Florida into that future.

Cautionary Language Concerning Forward-Looking Statements:

This release contains “forward-looking statements” that include information relating to future events and future financial and operating performance. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential,” and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for Hemp Naturals products, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in Hemp Naturals filings with the United States Securities and Exchange Commission. Examples of such forward-looking statements in this release include statements regarding future sales, costs and market acceptance of products as well as regulatory actions at the State or Federal level. For a more detailed description of the risk factors and uncertainties affecting Hemp Naturals please refer to the Company’s Securities and Exchange Commission filings, which are available at www.sec.gov. Hemp Naturals undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations:

Hempofnaturals@gmail.com
hempofnaturals.com
Hempnaturals.shop

SOURCE: Hemp Naturals Inc. 

View source version on accesswire.com:
https://www.accesswire.com/603770/Hemp-Naturals-Premium-CBD-Gummies-Are-Now-Available-Smokers-World

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

43 minutes ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

44 minutes ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

47 minutes ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

47 minutes ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

47 minutes ago

Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson’s Disease

MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…

47 minutes ago